Entrada Therapeutics, Inc

Entrada Therapeutics is a biopharmaceutical company based in the United States that is focused on developing intracellular therapeutics to treat devastating diseases. The company's proprietary EEV™ platform is designed to address the challenges of conventional intracellular therapeutics, offering a modular approach to efficiently expand into multiple therapeutic areas, including Duchenne muscular dystrophy and myotonic dystrophy type 1.